Skip to main content
SpringerLink
Log in

Prior Calcium Channel Blockade and Short-Term Survival Following Acute Myocardial Infarction

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

There is concern over the safety of calcium channel blockers (CCBs) in acute coronary disease. We sought to determine if patients taking calcium channel blockers (CCBs) at the time of admission with acute myocardial infarction (AMI) had a higher case-fatality compared with those taking beta-blockers or neither medication. Clinical and drug treatment variables at the time of hospital admission predictive of survival at 28 days were examined in a community-based registry of patients aged under 65 years admitted to hospital for suspected AMI in Perth, Australia, between 1984 and 1993. Among 7766 patients, 1291 (16.6%) were taking a CCB and 1259 (16.2%) a betablocker alone at hospital admission. Patients taking CCBs had a worse clinical profile than those taking a beta-blocker alone or neither drug (control group), and a higher unadjusted 28-day mortality (17.6% versus 9.3% and 11.1% respectively, both P < 0.001). There was no significant heterogeneity with respect to mortality between nifedipine, diltiazem, or verapamil when used alone, or with a beta-blocker. After adjustment for factors predictive of death at 28 days, patients taking a CCB were found not to have an excess chance of death compared with the control group (odds ratio [OR] 1.06, 95% confidence interval [CI]; 0.87, 1.30), whereas those taking a beta-blocker alone had a lower odds of death (OR 0.75, 95% CI; 0.59, 0.94). These results indicate that established calcium channel blockade is not associated with an excess risk of death following AMI once other differences between patients are taken into account, but neither does it have the survival advantage seen with prior beta-blocker therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stone PH, Antman EM, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med 1980; 93: 886-904.

    Google Scholar 

  2. Jiang H, Whelton PK. Selection of initial antihypertensive drug therapy. Lancet 2000; 356: 1942-1943.

    Google Scholar 

  3. Yusuf S, Held P, Furberg C. Update of calcium antagonists in myocardial infarction in light of the Second DanishVerapimil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991; 67: 1295-1297.

    Google Scholar 

  4. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.

    Google Scholar 

  5. The Multicentre Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. NEngl JMed 1988; 319: 385-92.11.

    Google Scholar 

  6. The Danish Group on Verapamil in Myocardial Infarction. The effect of verapamil on mortality and major events after acute myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT-II) Am J Cardiol 1990; 66: 779-785.

    Google Scholar 

  7. Gibson RS, Hansen JF, Messerli F, Schechtman KB, Boden WE. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: Post hoc subset analysis of the Multicenter Diltiazem Postinfarction Trial and the Second Danish Verapamil Infarction Trial studies. Am J Cardiol 2000; 86: 275-279.

    Google Scholar 

  8. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986; 2: 57-66.

    Google Scholar 

  9. Yusuf S, Peto R, Lewis J, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371.

    Google Scholar 

  10. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997: 277: 115-121.

    Google Scholar 

  11. Leitch JW, McElduff P, Dobson A, Heller R. Outcome with calcium channel antagonists after myocardial infarction: A community-based study. JAmColl Cardiol 1998; 31: 111-117.

    Google Scholar 

  12. Hugenholtz PG, Serrus PW, Fleckenstein A, Naylor W. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Eur Heart 1986; 7: 270-278.

    Google Scholar 

  13. Hobbs MST, Jamrozik K, Hockey RL, et al. Mortality from coronary heart disease and incidence of acute myocardial infarction in Auckland, Newcastle and Perth. Med J Aust 1991; 155: 436-442.

    Google Scholar 

  14. Tunstall-Pedoe H for the WHO MONICA Project Principal Investigators. TheWorld Health organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J Clin Epidemiol 1988; 41: 105-114.

    Google Scholar 

  15. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. For the WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project-registration procedures, event rates and case fatality in 38 populations from 21 countries in 4 continents. Circulation 1994; 90: 583-612.

    Google Scholar 

  16. Bell H, Parsons R, Jamrozik K, Frijters C. Trends in the treatment of non-fatal acute myocardial infarction at home in Perth, Western Australia, 1984-1993. ANZ J Med 1995; 25: 204-208.

    Google Scholar 

  17. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Standards and Procedures for Measurement and Classification. Boston: John Wright, 1982.

    Google Scholar 

  18. Parsons RW, Jamrozik KD, Hobbs MST, Thompson PL. Early identification of patients at low risk of death after myocardial infarction and potentially suitable for early hospital discharge. BMJ 1994; 308: 1006-1010.

    Google Scholar 

  19. Nidorf SM, Parsons RW, Thompson PL, Jamrozik K, Hobbs MST. Reduced risk of death at 28 days in patients taking a beta-blocker before admission to hospital with myocardial infarction. BMJ 1990; 300: 71-74.

    Google Scholar 

  20. Lee KL, Woodlief LH, Topol EJ, et al. For the GUSTO-1 Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. Circulation 1995; 91: 1659-1668.

    Google Scholar 

  21. Boden WE, van Gilst WH, Scheldewaert RG, et al. For the Incomplete Infarct Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Diltiazem in acute myocardial infarction treated with thrombolytic agents: A randomised placebo-controlled trial. Lancet 2000; 355: 1751-1756.

    Google Scholar 

  22. Braun S, Boyko V, Behar S, Reicher-Reiss H, et al. Calcium antagonists and mortality in patients with coronary artery disease:Acohort study of 11,575 patients. JAmColl Cardiol 1996; 28: 7-11.

    Google Scholar 

  23. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials. Lancet 2000; 356: 1949-1954.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health, University of Western Australia, Perth, Australia

    Richard W Parsons, Joseph Hung, Ingrid Hanemaaijer, Robyn J Broadhurst, Konrad Jamrozik & Michael ST Hobbs

Authors
  1. Richard W Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ingrid Hanemaaijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robyn J Broadhurst
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Konrad Jamrozik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael ST Hobbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsons, R.W., Hung, J., Hanemaaijer, I. et al. Prior Calcium Channel Blockade and Short-Term Survival Following Acute Myocardial Infarction. Cardiovasc Drugs Ther 15, 487–492 (2001). https://doi.org/10.1023/A:1013707503018

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013707503018

Search

Navigation